Larotrectinib Oral Solution and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Larotrectinib Oral Solution and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Larotrectinib Oral Solution-Moxifloxacin
- Larotrectinib Oral Solution-Moxifloxacin (Systemic)
- Larotrectinib Oral Solution-Moxifloxacin Hydrochloride
- Larotrectinib Oral Solution-Moxifloxacin Injection
- Larotrectinib Oral Solution-Moxifloxacin Intravenous
- Larotrectinib Oral Solution-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Larotrectinib Sulfate
- Moxetumomab pasudotox-tdfk Intravenous-Lartruvo
- Moxetumomab pasudotox-tdfk Intravenous-Larynex
- Moxetumomab pasudotox-tdfk Intravenous-Laryng-O-Jet
- Moxetumomab pasudotox-tdfk Intravenous-Laryngesic
- Moxetumomab pasudotox-tdfk Intravenous-Lasix